<DOC>
	<DOCNO>NCT02927106</DOCNO>
	<brief_summary>In study , DNA sequencing , computational biology modeling , ex vivo drug sensitivity assay utilized define clinically relevant gene mutation identify potential therapeutic patient acute myeloid leukemia ( AML ) .</brief_summary>
	<brief_title>Beat AML Core Study</brief_title>
	<detailed_description>As part normal clinical care , patient undergo peripheral blood draw bone marrow aspiration &amp; biopsy . Blood draw bone marrow aspiration perform time diagnosis , treatment , disease progression , relapse . Under normal clinical care , patient specimen analyze cytogenetics ( giemsa stain ) , fluorescence situ hybridization ( FISH ) , gene mutation profile . Clinically , treatment begin molecular diagnostics available . As part repository study , subject ask : - Allow access bank blood bone marrow specimens IRB approve protocol # 532-2012 . - Donate peripheral blood specimen whenever blood already draw clinical purpose time diagnosis , relapse , refractory disease disease progression . Additional sample may request standard care visit event initial sample viable DNA sequencing , phenotyping , functional assay patient AML , disease present . - Donate bone marrow aspirate specimen whenever bone marrow aspiration already do clinical purpose time diagnosis , relapse , refractory disease disease progression . If bone marrow aspirate collect banking protocol # 532-2012 , aliquot bank specimen access rather collect additional bone marrow aspirate study . - Undergo skin biopsy donate skin biopsy specimen genomic profiling . - Allow bone marrow , peripheral blood skin biopsy specimen collect genomic profiling ex vivo drug sensitivity testing .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Myeloid</mesh_term>
	<mesh_term>Leukemia , Myeloid , Acute</mesh_term>
	<criteria>Individuals newly diagnose relapsed/refractory Acute Myeloid Leukemia ( AML ) define World Health Organization 2016 . â‰¥ 18 year age Capable providing inform consent 17 year age less great 80 year age</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>leukemia</keyword>
	<keyword>myeloid</keyword>
	<keyword>genomics</keyword>
</DOC>